A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET)

NCT01081652 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Infertility

Interventions

DRUG: Micronised Progesterone
DRUG: Progesterone

Sponsor

Merck KGaA, Darmstadt, Germany